SCHEMBL21532201

SCHEMBL21532201

c1ccc(-c2nnc(-c3ccc4c5ccccc5n(-c5ccccc5-c5ccccc5-n5c6ccccc6c6cc7oc8ccccc8c7cc65)c4c3)n2-c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 1/20 0.36
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 3/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.34
HPGD P15428 2/20 0.34
MAPT P10636 2/20 0.34
RGS12 O14924 1/20 0.34
USP2 O75604 1/20 0.34
POLB P06746 1/20 0.34
ALOX15 P16050 1/20 0.34
APOBEC3A P31941 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33
AKT1 P31749 2/20 0.33
METAP2 P50579 2/20 0.32
GLA P06280 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532209 0.97 AVPR1A (0.35) AVPR1AKDM4EALDH1A1HSD17B10TSHR
SCHEMBL21532502 0.96 AVPR1A (0.36) AVPR1AKDM4EALDH1A1HSD17B10TSHR
SCHEMBL21532311 0.95 AVPR1A (0.38) AVPR1AKDM4EALDH1A1HSD17B10TSHR
SCHEMBL21532526 0.94 KDM4E (0.33) AVPR1AKDM4EALDH1A1HSD17B10TSHR
SCHEMBL21532203 0.93 ALDH1A1 (0.36) KDM4EALDH1A1HSD17B10TSHRSMN1; SMN2
SCHEMBL21532653 0.92 KDM4E (0.34) AVPR1AKDM4EALDH1A1HSD17B10TSHR
SCHEMBL21532306 0.92 AVPR1A (0.37) AVPR1AKDM4EALDH1A1HSD17B10TSHR
SCHEMBL21532528 0.92 KDM4E (0.33) AVPR1AKDM4EALDH1A1HSD17B10TSHR
SCHEMBL21532207 0.91 ALDH1A1 (0.36) KDM4EALDH1A1HSD17B10TSHRSMN1; SMN2
SCHEMBL21532158 0.91 AVPR1A (0.38) AVPR1AKDM4EALDH1A1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 AVPR1A 694/4885KDM4E 4144/4885ALDH1A1 158/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 AVPR1A 475/4885KDM4E 3893/4885ALDH1A1 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.